Development and Effect of Physical Activity Program using Taichi for rheumatiod arthritis

Development and Effect of Physical Activity Program using Taichi for Postmenopausal Women with Risk of Osteosarcopenia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004683

Enrollment

Registered

2020-01-31

Start date

2019-12-11

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : A total of 16 weeks of program for 8 weeks of Taichi-based physical activity program intervention and 8 weeks of expert telephone interviews and 6 individual SNS sessions.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.A person who has been diagnosed with rheumatoid arthritis by a rheumatologist (American College of Rheumatology Criteria, 2010) 2. Menopause (Early Menopause) Women 1. Menopause meets one or more of the following three conditions (WHO, 1994) 1) 12 months of spontaneous amenorrhea 2) Patients with spontaneous amenorrhea for 6 months and serum FSH=40mIU / mL 3) Patients who passed 6 weeks after bilateral ovarian resection with or without hysterectomy 3. Bone density values ??less than -1.0 SD or at least one osteoporotic vertebral fracture measured at the lumbar spine or femur (femoral neck or whole femur) (WHO, 1994) 4. Person who measured DEXA (dual energy x-ray absorptiometry) within 1 year Those who are satisfied with one of the muscle function evaluation items, ie, low muscle mass (aLM / Ht=5.4kg / m on DXA or BIA, Low muscle strength (grip strength <18kg), Low physical performance (gait speed <0.8m / s)) 5. A person judged to be able to participate in exercise program

Exclusion criteria

Exclusion criteria: 1. A person diagnosed with autoimmune or inflammatory joint disease or malignant tumor in addition to rheumatoid arthritis 2. Take 3 months or more with 7.5mg oral steroid 3. Participants in other exercise programs while participating in the research 4. Those who have less than 70% participation in the program

Design outcomes

Primary

Measure	Time frame
Physical activity, bone function, disease activity, physical activity self-efficacy, health-related quality of life	—

Secondary

Measure	Time frame
Fatigue, drug performance, fear of falls, depression,	—

Countries

Korea, Republic of

Contacts

Public ContactHyewon Yun

Ajou University Hospital

Outcome results